InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Rojkjaer Lisa, Directeur Médical. Insider active across 2 companies, notably Viracta Therapeutics, Inc.. Aggregated, 6 disclosures have been published. The latest transaction was filed on 25 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
04,127 shares0
Common Stock
SEC:0001209191-22-032670:0·
04,127 shares0
Common Stock
SEC:0001209191-22-014441:0·
08,254 shares0
Common Stock
SEC:0001209191-21-067046·
08,254 shares0
Common Stock
SEC:0001209191-21-067046:0·
€33,91532,689 shares@ €1.0375100.0% of flow
Common Stock
SEC:0001209191-21-032413·
€33,91532,689 shares@ €1.037550.0% of flow
Common Stock
SEC:0001209191-21-032413:0·
6 of 6 declarations
About Rojkjaer Lisa
Lisa Rojkjaer is the Chief Medical Officer at Viracta Therapeutics, Inc. She is responsible for the strategic direction of the company's medical initiatives, ensuring that research and development programs meet the highest standards. Lisa plays a key role in guiding clinical efforts and collaborating with research teams to develop innovative treatments. Her expertise contributes to advancing Viracta's objectives in the field of oncology therapies.
